Exploring the health and wellness news of Tuvalu
Provided by AGPCHICAGO, May 13, 2026 (GLOBE NEWSWIRE) -- Despite last summer’s widely publicized insurer pledge to improve prior authorization, new survey data from the American Medical Association (AMA) show physicians are pervasively skeptical that meaningful change will occur—reflecting years of similar commitments that have failed to produce lasting improvements.
In June 2025, after successful engagement from the Trump administration to address widespread concerns from patients and physicians, roughly 60 health insurers pledged to streamline, simplify, and reduce prior authorization requirements, with implementation deadlines spanning 2025 through 2027. Ahead of the first major deadline, the AMA surveyed 1,000 practicing physicians to assess whether these commitments are likely to deliver meaningful improvements for patients and physicians.
Findings from the 2025 AMA Prior Authorization Physician Survey show that only one in three physicians (33%) believe the latest insurer pledge will make a meaningful difference.
Physician skepticism is grounded in experience. As part of the 2025 pledge, insurers committed to ensuring that all medical necessity denials would be reviewed by a licensed and qualified clinician. Yet only one in four physicians (24%) report that such reviews are consistently conducted by appropriately qualified clinicians. In addition, just 16% of physicians who participate in peer-to-peer reviews say the health plan representative often or always has the appropriate qualifications.
“Physician trust in voluntary insurer pledges is deeply eroded after years of unfulfilled promises,” said AMA President Bobby Mukkamala, M.D. “Physicians are especially frustrated when so-called peer-to-peer reviews are conducted by individuals who lack the appropriate clinical expertise to evaluate a patient’s care. When only a third of physicians expect meaningful impact—and so few report that health plan reviewers are appropriately qualified—it highlights a credibility gap that won’t be closed with vague or partial measures. Rebuilding trust will require sustained, transparent, and measurable action to streamline prior authorization and keep it clinically focused and patient-centered. Anything less risks reinforcing the skepticism these pledges were meant to address.”
The AMA survey shows how much work insurers still must do and highlights ongoing concerns that prior authorization delays care, disrupts treatment, and harms patient outcomes.
Prior authorization also continues to place significant strain on physician practices, driving high volumes of requests and denials, consuming clinical and administrative time, and contributing to widespread burnout. As administrative demands intensify, resources are increasingly diverted from patient care to manage an inefficient process.
Beyond its impact on patients and physician practices, prior authorization also drives inefficiencies and unnecessary costs across the health system.
Physicians also report consistently high administrative burden with prior authorization across all major health insurers. UnitedHealthcare (75%) tops the ranks for “high” or “extremely high” burden, followed by Humana (65%), Anthem/Elevance (61%), Aetna (61%), Cigna (59%), and Blue Cross Blue Shield (56%).
The AMA continues to work on every front in support of prior authorization reforms that prioritize patients’ access to necessary care and reduce administrative burdens for physicians. The AMA looks forward to continuing to work with the Trump administration, Congress and health insurers on this critical issue. To learn more about prior authorization challenges experienced by patients, physicians, and employers, go to FixPriorAuth.org.

AMA Media & Editorial American Medical Association 312-464-4430 media@ama-assn.org
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.